Valuation: Cogstate Limited

Market Cap 626M 429M 387M 357M 323M 611M 40.24B 4.28B 1.71B 21.55B 1.61B 1.58B 68.58B P/E 2027 *
28.9x
P/E 2028 * 22.4x
Enterprise Value 561M 385M 347M 320M 290M 548M 36.07B 3.84B 1.53B 19.32B 1.44B 1.41B 61.48B EV / Sales 2027 *
5.16x
EV / Sales 2028 * 4.35x
Free-Float
56.72%
Yield 2027 *
1.37%
Yield 2028 * 1.68%
1 day+3.30%
1 week+11.24%
Current month+8.99%
1 month-1.05%
3 months+36.73%
6 months+52.23%
Current year+66.37%
1 week 3.22
Extreme 3.22
3.84
1 month 3.22
Extreme 3.22
3.95
Current year 2.01
Extreme 2.01
3.98
1 year 1.75
Extreme 1.75
3.98
3 years 0.8
Extreme 0.795
3.98
5 years 0.8
Extreme 0.795
3.98
10 years 0.16
Extreme 0.155
3.98
Manager TitleAgeSince
Chief Tech/Sci/R&D Officer - 1999-12-16
Chief Executive Officer - 2005-11-30
Director of Finance/CFO - 2021-01-31
Director TitleAgeSince
Director/Board Member - 2011-02-28
Chairman 67 2009-11-02
Director/Board Member - 2017-01-19
Date Insider Type Main position Quantity % Market Cap. Importance
10/30/26 Free

Chief Executive Officer

355,866 0.2061%
10/29/26 Exercice

Chief Executive Officer

-500,000 0.2907%
10/29/26 Sell

Chief Executive Officer

-500,000 0.2907%
Change 5-day change 1-year change 3-year change Capi.($)
+3.30%+11.24%+31.01%+141.03% 429M
-1.06%-0.07%+60.76%+68.61% 67.53B
+1.30%+7.41%+14.79%+92.69% 60.74B
+0.39%+0.30%+20.04%+98.33% 55.66B
-0.95%+11.17%+22.21%+110.93% 47.97B
-0.23%+4.07%+25.63%+40.08% 45.24B
-6.40%-9.51%+181.99%+816.79% 39.08B
+1.97%+3.50%+25.78%+50.98% 35.34B
-0.56%-0.48%+85.57%+65.40% 33.45B
+1.05%+9.77%-37.66%+408.42% 26.49B
Average -0.12%+2.39%+43.01%+189.33% 41B
Weighted average by Cap. -0.48%+1.65%+44.29%+169.11%

Financials

2027 *2028 *
Net sales 109M 74.56M 67.2M 62.08M 56.12M 106M 6.99B 744M 297M 3.75B 280M 274M 11.92B 125M 85.73M 77.27M 71.39M 64.54M 122M 8.04B 856M 341M 4.31B 322M 315M 13.7B
Net income 21.75M 14.91M 13.44M 12.41M 11.22M 21.23M 1.4B 149M 59.29M 749M 55.95M 54.76M 2.38B 27.77M 19.03M 17.15M 15.85M 14.33M 27.11M 1.79B 190M 75.7M 956M 71.43M 69.91M 3.04B
Net Debt -64.78M -44.39M -40.01M -36.96M -33.41M -63.22M -4.16B -443M -177M -2.23B -167M -163M -7.1B -82.32M -56.41M -50.84M -46.97M -42.46M -80.33M -5.29B -563M -224M -2.83B -212M -207M -9.02B
Projected Income Statement - Annual - Cogstate Limited
Logo Cogstate Limited
Cogstate Limited is a neuroscience technology company optimizing brain health assessments to advance the development of new medicines and to enable earlier clinical insights in healthcare. Its principal activities are the creation, validation, and commercialization of digital brain health assessments; and design and provision of quality assurance services in clinical trials, focused on the administration, scoring, and recording of conventional brain health assessments. Its segments include Clinical Trials, Healthcare, and Administration. In the Clinical Trials segment, the technology and associated services are used to quantify the effect of disease and of drugs, devices or other interventions on human subjects participating in clinical trials primarily conducted by pharmaceutical, and biotechnology companies. In the Healthcare segment, the technology and associated services are being developed as a tool for primary care physicians and/or hospitals to assess cognitive decline.
Employees
160
Date Price Change Volume
26-11-12 A$3.760 +3.30% 171,621
26-11-11 A$3.640 +1.11% 683,685
26-11-10 A$3.600 +7.14% 1,104,693
26-11-09 A$3.360 +2.13% 220,119
26-11-06 A$3.290 -2.66% 97,840
Trader
Investor
Global
Quality
ESG MSCI
-
MarketScreener Ratings - Cogstate Limited
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
3.640AUD
Average target price
4.497AUD
Spread / Average Target
+23.54%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Cogstate Limited